Treasurer of the State of North Carolina’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.71M Buy
24,933
+536
+2% +$93.7K 0.01% 631
2025
Q4
$4.15M Sell
24,397
-1,789
-7% -$274K 0.01% 666
2025
Q3
$3.45M Sell
26,186
-49,782
-66% -$5.97M 0.01% 745
2025
Q2
$8.06M Buy
75,968
+47,406
+166% +$5.15M 0.03% 505
2025
Q1
$3.55M Buy
28,562
+494
+2% +$64.4K 0.01% 699
2024
Q4
$3.46M Sell
28,068
-328
-1% -$38.7K 0.01% 728
2024
Q3
$3.16M Buy
28,396
+426
+2% +$46.7K 0.01% 744
2024
Q2
$2.98M Sell
27,970
-158
-0.6% -$17.4K 0.01% 750
2024
Q1
$3.39M Buy
28,128
+182
+0.7% +$22.3K 0.01% 710
2023
Q4
$3.44M Sell
27,946
-501
-2% -$62.5K 0.02% 685
2023
Q3
$3.68M Sell
28,447
-1,817
-6% -$242K 0.02% 620
2023
Q2
$3.75M Sell
30,264
-35
-0.1% -$4.71K 0.02% 626
2023
Q1
$4.43M Buy
30,299
+440
+1% +$65.1K 0.03% 556
2022
Q4
$4.76M Buy
29,859
+2,920
+11% +$428K 0.03% 532
2022
Q3
$3.59M Buy
26,939
+1,160
+4% +$176K 0.02% 592
2022
Q2
$4.02M Buy
25,779
+3,704
+17% +$570K 0.03% 568
2022
Q1
$3.44M Buy
22,075
+350
+2% +$50.8K 0.02% 606
2021
Q4
$2.77M Buy
21,725
+380
+2% +$49.9K 0.01% 710
2021
Q3
$2.78M Sell
21,345
-148
-0.7% -$22.4K 0.02% 694
2021
Q2
$3.82M Buy
21,493
+478
+2% +$82.8K 0.02% 593
2021
Q1
$3.45M Sell
21,015
-2,630
-11% -$433K 0.02% 606
2020
Q4
$3.9M Sell
23,645
-3,730
-14% -$556K 0.03% 550
2020
Q3
$3.9M Sell
27,375
-2,900
-10% -$360K 0.03% 499
2020
Q2
$3.34M Sell
30,275
-9,661
-24% -$1.07M 0.03% 506
2020
Q1
$3.98M Buy
39,936
+9,680
+32% +$1.25M 0.04% 423
2019
Q4
$4.52M Sell
30,256
-90
-0.3% -$12.2K 0.04% 345
2019
Q3
$3.89M Sell
30,346
-9,451
-24% -$1.27M 0.04% 360
2019
Q2
$5.67M Buy
39,797
+3,560
+10% +$478K 0.03% 425
2019
Q1
$5.18M Buy
36,237
+6,777
+23% +$884K 0.03% 439
2018
Q4
$3.65M Buy
29,460
+5,370
+22% +$797K 0.03% 518
2018
Q3
$4.05M Buy
24,090
+10,486
+77% +$1.8M 0.03% 541
2018
Q2
$2.34M Buy
+13,604
New +$2.22M 0.02% 529

Other funds holding JAZZ

Treasurer of the State of North Carolina's JAZZ Position: Q1 2026 in Review

Treasurer of the State of North Carolina increased its Jazz Pharmaceuticals (JAZZ) stake by 2.2% in Q1 2026, buying an estimated $93.7K and bringing the position to 24,933 shares worth $4.71M. The position accounts for 0.01% of the portfolio, ranked #631.

Treasurer of the State of North Carolina first reported a position in JAZZ in Q2 2018 and has held it in 32 quarters since. The position peaked at $8.06M in Q2 2025. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Treasurer of the State of North Carolina held 24,933 shares of Jazz Pharmaceuticals worth $4.71M as of Q1 2026.
  • Treasurer of the State of North Carolina bought 536 Jazz Pharmaceuticals shares in Q1 2026, an estimated $93.7K.
  • Jazz Pharmaceuticals made up 0.01% of Treasurer of the State of North Carolina's portfolio in Q1 2026, its #631 holding.
  • Treasurer of the State of North Carolina first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 32 quarters since.
  • Treasurer of the State of North Carolina's Jazz Pharmaceuticals position peaked at $8.06M in Q2 2025.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q1 2026, filed 14 May 2026.